India Supreme Court dismisses Novartis patent case

On April 1, the Indian Supreme Court denied Novartis' appeal challenging the rejection of a patent for its cancer drug Glivec (imatinib mesylate), which has been patented in almost 40 countries including China, Russia, and Taiwan. » More

Continuing Education

LIVE EVENT!

Medication Therapy Management for Patients with Diabetes CPE Series

Reserve the dates—May 22 or May 23—to attend an innovative 6-hour live program at the University of Connecticut School of Pharmacy campus. Learn motivational interviewing skills, apply medication therapy management concepts to patients with diabetes, and practice your new skills to earn 6 CPE credits and a certificate of achievement (additional 6 CPE credits are awarded for post-activity requirements) – for a total of 12 CPE credits.

Prerequisite: Completion prior to the event of the 7 knowledge-based and 3 application-based activities in this CPE series by University of Connecticut School of Pharmacy and Drug Topics.

Click here for more information and to register.

Diabetes CPE Series: March activity available now

Welcome to the seventh and last knowledge-based activity in our CPE series: Medication Therapy Management (MTM) in Patients with Diabetes, which has been designed for pharmacists who take care of patients with diabetes. You can earn up to 14 credits from September 2012-March 2013 with 7 monthly knowledge-based activities. The March activity covers drug-induced hyperglycemia and hypoglycemia, nonprescription medications, and complementary and alternative medicine for diabetes care.

To read and print the article with TEST QUESTIONS, click here. To proceed to the online exams and earn up to 2 CPE credits, click here to login.

New online interactive case studies available now

Welcome to Case Studies in Diabetes Care-Part 1. This is the first of three studies offering you an opportunity to apply diabetes management concepts from the knowledge-based diabetes series. Earn 1 hour of CPE credit by completing this application-based activity.

Announcement: Welcome to the new user registration process. This new process requires all pharmacists and pharmacy technicians to provide or update their NABP e-Profile ID in order to electronically keep track of CPE credits from ACPE-accredited providers. If you have not done so, you can obtain your NABP e-Profile ID now at www.MyCPEmonitor.net. This profile will enable you to have one login for all the NABP programs and services you will need throughout your career.

Today's Headlines

Niacin ER with statins doesn't reduce CV outcomes

The use of extended-release niacin as an adjunct to statins does not reduce the risk of a heart attack or stroke in patients with pre-existing cardiovascular disease, according to researchers who led the HPS2-THRIVE study. The results of the study were reported at the American College of Cardiology conference in San Francisco on March 9. » More

CDC warns about need for CRE prevention

The Centers for Disease Control and Prevention (CDC) reported that carbapenem-resistant Enterobacteriaceae (CRE) has increased over the last decade and most cases of resistance are associated with healthcare exposures. » More

TAKE OUR SURVEY

India's Supreme Court denied Novartis AG's attempt to secure a patent for its cancer drug, Glivec, setting a benchmark for intellectual property cases in India.

Do you think this case will create a chilling effect for other pharmaceutical companies doing business in India?

— Yes

— No

Click Here to let us know.

Check these out too

• Canagliflozin approved by FDA for diabetes

• Risk of ondansetron taken during pregnancy

• More Liraglutide increases weight loss

• BoP Specialties wants council nominations

• Guglielmo takes over at UCSF Pharm School

Voices

Anticoagulation Update